Recon: FDA adds warnings on Abbvie, Lilly and Pfizer JAK drugs; EMA recommends Roche arthritis drug for severe COVID
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy